The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Open accessAbstract
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-aspartate receptor (NMDAR). RESULTS: Twelve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and decreased level of consciousness often requiring ventilatory support. All had serum/cerebrospinal fluid antibodies that predominantly immunolabeled the neuropil of hippocampus/forebrain, in particular the cell surface of hippocampal neurons, and reacted with NR2B (and to a lesser extent NR2A) subunits of the NMDAR. NR2B binds glutamate and forms heteromers (NR1/NR2B or NR1/NR2A/NR2B) that are preferentially expressed in the adult hippocampus/forebrain. Expression of functional heteromers (not single subunits) was required for antibody binding. Eleven patients had teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors examined contained nervous tissue that strongly expressed NR2 subunits and reacted with patients' antibodies. Tumor resection and immunotherapy resulted in improvement or full recovery of eight of nine patients (paralleled by decreased antibody titers); two of three patients without tumor resection died of neurological deterioration. Autopsies showed extensive microgliosis, rare T-cell infiltrates, and neuronal degeneration predominantly involving, but not restricted to, the hippocampus. INTERPRETATION: Antibodies to NR2B- and NR2A-containing heteromers of the NMDAR associate with a severe but treatment-responsive encephalitis. Our findings provide a diagnostic test and suggest a model of autoimmune NMDAR-related encephalitis with broad implications for other immune-mediated disorders of memory, behavior, and cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies suggested the target epitopes were located in extracellular regions of NR1–NR2B NMDA receptors.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“We recently identified a disorder, designated anti-NMDA-receptor encephalitis, that associates with antibodies against NR1–NR2 heteromers and results in a characteristic neuropsychiatric syndrome.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“The first patients identified were young women with ovarian teratoma who presented with psychosis or memory problems, rapidly progressing to multiple neurological deficits requiring prolonged intensive care support.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Serum and CSF were tested for antibodies against the NMDA receptor,5 and considered positive if three immunohistochemical criteria were fulfilled (figure 1).”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Despite the severity of the disorder, patients often recovered after tumour removal and immunotherapy, suggesting an immune-mediated pathogenesis.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,110
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 891
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. O. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 776
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S. A., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C. B., Key, G., D'Amato, L., Sabattini, E., Feudale, E. A. A., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W. P., Ances, B. M., Zwerdling, T., Jiang, Z., & Dalmau, J. O. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A. D., Houghton, D. J., Galetta, S. L., Dichter, M. A., Alavi, A. A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 486
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Wenzel, A., Fritschy, J., Möhler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 442
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,000
Autoantikörper-assoziierte schizophreniforme Psychosen: klinische Symptomatik
Endres, D., Bechter, K., Prüß, H., Hasan, A., Steiner, J. H., Leypoldt, F., & van Elst, L. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0700-z · Cited by 28
Sleep Disturbances in Patients with Autoimmune Encephalitis
Blattner, M. S., & Day, G. S. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01048-0 · Cited by 29
Marchi, M., Galli, G., Magarini, F. M., Mattei, G., & Galeazzi, G. M. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1885648 · Cited by 29
Gono, T., Takarada, T., Fukumori, R., Kawaguchi, Y., Kaneko, H., Hanaoka, M., Katsumata, Y., Yoneda, Y., & Yamanaka, H. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30616 · Cited by 27
Steiner, J. H., Schiltz, K., Bernstein, H., & Bogerts, B. (2015) · CNS Drugs · doi:10.1007/s40263-015-0233-3 · Cited by 28
Maternal-Fetal Transfer of Anti–N-Methyl-D-Aspartate Receptor Antibodies
Lamale‐Smith, L. M., Moore, G. S., Guntupalli, S. R., & Scott, J. B. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000548 · Cited by 29
Autoantibodies in Neuropsychiatric Disorders
Hoffmann, C., Zong, S., Mané-Damas, M., Molenaar, P. C., Losen, M. H., & Martínez‐Martínez, P. (2016) · Antibodies · doi:10.3390/antib5020009 · Cited by 30
The Differential Diagnosis and Treatment of Catatonia in Children and Adolescents
Hauptman, A. J., & Benjamin, S. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000114 · Cited by 29
Gable, M., & Glaser, C. A. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.01.023 · Cited by 29
Autoantibody-Associated Movement Disorders in Children: Proven and Proposed
Singer, H. S. (2017) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2017.08.003 · Cited by 29
Long‐term outcome of paediatric anti‐ N ‐methyl‐D ‐ aspartate receptor encephalitis
Flet‐Berliac, L., Tchitchek, N., Lepine, A. F., Florea, A., Maurey, H., Chrétien, P., Hacein‐Bey‐Abina, S., Villega, F., Cheuret, E., Rogemond, V., et al. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15429 · Cited by 28
Autoimmune channelopathies in paraneoplastic neurological syndromes
Joubert, B., & Honnorat, J. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.04.003 · Cited by 30
Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
Vališ, M., Masopust, J., Andrýs, C., Bažant, J., Vyšata, O., & Kuča, K. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s80746 · Cited by 28
Pediatric Anti- N -Methyl- D -Aspartate (NMDA) Receptor Encephalitis
Chakrabarty, B., Tripathi, M., Gulati, S., Yoganathan, S., Pandit, A. K., Sinha, A. P., & Rathi, B. S. (2013) · Journal of Child Neurology · doi:10.1177/0883073813494474 · Cited by 28
Survey of the diagnostic and therapeutic approach to new-onset refractory status epilepticus
Kang, C. M. C., Gaspard, N., LaRoche, S. M., & Foreman, B. P. (2017) · Seizure · doi:10.1016/j.seizure.2017.02.003 · Cited by 28
Ferrafiat, V., Raffin, M., Freri, E., Granata, T., Nardocci, N., Zibordi, F., Bodeau, N., Benarous, X., Olliac, B., Riquin, É., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.036 · Cited by 28
Anti‐NMDA‐receptor encephalitis during pregnancy: A case report and literature review
Xiao, X. H., Gui, S., Bai, P., Bai, Y., Shan, D., Hu, Y., Bui‐Nguyen, T. M., & Zhou, R. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13262 · Cited by 28
Limotai, C., Denlertchaikul, C., Saraya, A. W., & Jirasakuldej, S. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.04.007 · Cited by 27
Pruetarat, N., Netbaramee, W., Pattharathitikul, S., & Veeravigrom, M. (2019) · Brain and Development · doi:10.1016/j.braindev.2018.12.009 · Cited by 28
Sperber, P. S., Siegerink, B., Huo, S., Rohmann, J. L., Piper, S. K., Prüß, H., Heuschmann, P. U., Endres, M., & Liman, T. (2019) · Stroke · doi:10.1161/strokeaha.119.026100 · Cited by 28
Aetiology and pathogenesis of paraneoplastic autoimmune disorders
Geng, G., Yu, X., Jiang, J., & Yu, X. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102422 · Cited by 28
Gallus, M., Roll, W., Dik, A., Barca, C., Zinnhardt, B., Hicking, G., Mueller, C., Naik, V. N., Anstötz, M., Krämer, J., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq7595 · Cited by 27
Uchino, A., Iizuka, T., 浦野義章, Arai, M., Hara, A., Hamada, J., Hirose, R., Dalmau, J. O., & Mochizuki, H. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4764 · Cited by 27
Anti–N-methyl-D-aspartate Receptor Encephalitis
Ferioli, S., Dalmau, J. O., Kobet, C. A., Zhai, Q. “., Broderick, J. P., & Espay, A. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.317 · Cited by 27
Diagnóstico diferencial en la encefalitis por anticuerpos contra el receptor NMDA
Gonzalez-Valcarcel, J., Rosenfeld, M. R., & Dalmau, J. O. (2010) · Neurología · doi:10.1016/j.nrl.2010.03.007 · Cited by 27
Pregnancy Outcome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Magley, J., Towner, D., Taché, V., & Apperson, M. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31825935d4 · Cited by 28
Seroprevalence of anti-N-methyl-d-aspartate receptor antibodies in women with ovarian teratoma
Mangler, M., Trebesch, I., Teegen, B., STÖCKER, W., Prüß, H., Meisel, A., Schneider, A., Vasiljeva, J., & Speiser, D. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7074-0 · Cited by 28
Paraneoplastic neurologic syndromes in children: a review article.
Alavi, S. (2013) · Iranian journal of child neurology. · doi:10.22037/ijcn.v7i3.4958 · Cited by 28
Practice Current: How do you treat anti-NMDA receptor encephalitis?
Bartolini, L. (2016) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000219 · Cited by 29
Cardinal, R. N., & Bullmore, E. T. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511686917 · Cited by 28
The HMGB 1 is increased in CSF of patients with an Anti‐ NMDAR encephalitis
Ai, P., Zhang, X., Xie, Z., Liu, G., Liu, X., Pan, S., & Wang, H. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12850 · Cited by 29
Pollak, T. A., & Lennox, B. (2018) · BJPsych Open · doi:10.1192/bjo.2018.27 · Cited by 28
NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies
Steinke, S., Kirmann, T., Loi, E. A., Nerlich, J., Weichard, I., Kühn, P., Bullmann, T., Ritzau‐Jost, A., Rizalar, F. S., Prüß, H., et al. (2022) · Brain · doi:10.1093/brain/awac497 · Cited by 28
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis
Masciocchi, S., Businaro, P., Scaranzin, S., Morandi, C., Franciotta, D. M., & Gastaldi, M. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2247482 · Cited by 28
Molecular Pathogenesis of Anti-NMDAR Encephalitis
Ding, H., Jian, Z., Stary, C. M., Yi, W., & Xiong, X. (2015) · BioMed Research International · doi:10.1155/2015/643409 · Cited by 28
Status Epilepticus: A Review, With Emphasis on Refractory Cases
Hunter, G. R. W., & Young, G. B. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013160 · Cited by 27
CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model
Gebauer, C., Pignolet, B., Yshii, L., Mauré, E., Bauer, J., & Liblau, R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1260212 · Cited by 27
Nosadini, M., Mohammad, S. S., Toldo, I., Sartori, S., & Dale, R. C. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.09.008 · Cited by 27
Autism Associated With Anti-NMDAR Encephalitis: Glutamate-Related Therapy
Tzang, R., Chang, C., Chang, Y., & Lane, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00440 · Cited by 27
Zhang, X., Wang, C., Zhu, W., Wang, B., Liang, H., & Guo, S. (2019) · Journal of Clinical Neurology · doi:10.3988/jcn.2019.15.3.369 · Cited by 27
Diminished toll-like receptor response in febrile infection-related epilepsy syndrome (FIRES)
Hsieh, M., Lin, J., Hsia, S., Huang, J., Yeh, K., Chang, K.-W., & Lee, W. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.05.007 · Cited by 28
Giné-Servén, E., Boix-Quintana, E., Ramírez, M. M., Guanyabens, N., Muriana, D., Guasp, M., Rivas, C. T., Daví-Loscos, E., & Casado, V. (2020) · Brain and Behavior · doi:10.1002/brb3.1980 · Cited by 27
Saidha, S., Murphy, S. M., Ronayne, A., McCarthy, P., Hennessy, M. J., & Counihan, T. J. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5476-9 · Cited by 27
Lascano, A. M., Korff, C. M., & Picard, F. (2016) · Molecular Syndromology · doi:10.1159/000447707 · Cited by 31
Staley, E. M., Jamy, R., Phan, A. Q., Figge, D. A., & Pham, H. P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00304 · Cited by 27
Evaluation and Management of Autoimmune Encephalitis
Mooneyham, G. C., Gallentine, W. B., & Mater, H. V. (2017) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2017.08.011 · Cited by 26
Review: Molecular pathology of frontotemporal lobar degenerations
Borroni, B., Alberici, A., & Buratti, E. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12534 · Cited by 26
Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy
Moussa, T., Afzal, K. I., Cooper, J. J., Rosenberger, R., Gerstle, K., & Wagner‐Weiner, L. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-019-0310-0 · Cited by 26
Zhang, L., Lu, Y., Xu, L., Liu, L., Wu, X., Zhang, Y., Zhu, G., & Hong, Z. (2019) · Seizure · doi:10.1016/j.seizure.2019.12.016 · Cited by 26
The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
Bechter, K. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00773 · Cited by 24
Shu, Y., Guo, J., Ma, X., Yan, Y., Wang, Y., Chen, C., Sun, X., Wang, H., Yin, J., Long, Y., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14596 · Cited by 26
Clinical features of paediatric and adult autoimmune encephalitis: A multicenter sample
Roliz, A. H., Shah, Y. D., Morse, A. M., Troester, M. M., Lynch, R., Pickle, J., Karkare, S. N., Fernandez-Carbonell, C., & Kothare, S. V. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.01.001 · Cited by 26
HSV encephalitis triggered anti-NMDAR encephalitis: a case report
Hu, S., Lan, T., Bai, R., Jiang, S., Cai, J., & Ren, L. (2021) · Neurological Sciences · doi:10.1007/s10072-020-04785-9 · Cited by 27
Clinical characteristics, treatment and long-term prognosis in patients with anti-NMDAR encephalitis
Raja, P., Biswas, S., Nitish, L. K., Holla, V. V., Pal, P. K., Mahadevan, A., Thomas, P. T., Maya, B., Saini, J. S., Hegde, S., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05174-6 · Cited by 25
Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis
Wilke, J. B. H., Hindermann, M., Berghoff, S. A., Zihsler, S., Arinrad, S., Ronnenberg, A., Barnkothe, N., Steixner-Kumar, A. A., Röglin, S., STÖCKER, W., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01238-3 · Cited by 26
Antibody-mediated autoimmune encephalitis: A practical approach
Abbatemarco, J., Chen, Y., Kunchok, A. C., & Rae-Grant, A. D. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20122 · Cited by 27
Guo, W., Huang, C., Kang, Y., Zhang, B., Li, B., Qiu, C., Liu, S., Ren, H., Yang, Y., Liu, X., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82930 · Cited by 25
Extensive myelitis associated with anti-NMDA receptor antibodies
Outteryck, O., Baille, G., Hodel, J., Giroux, M., Lacour, A., Honnorat, J., Zéphir, H., & Vermersch, P. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-211 · Cited by 27
Autoantibodies and the Immune Hypothesis in Psychotic Brain Diseases: Challenges and Perspectives
Pathmanandavel, K., Starling, J., Dale, R. C., & Brilot, F. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/257184 · Cited by 27
Zhang, J., Xu, X., Zhao, S., Gong, Z., Liu, P., Guan, W., He, X., Wang, T., Peng, T., Teng, J., et al. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0489-6 · Cited by 26
Central Neurogenic Hyperventilation in Anti-NMDA Receptor Encephalitis
Vural, A., Arsava, E. M., Dericioğlu, N., & Topçuoğlu, M. A. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.8215 · Cited by 26
Takano, S., Takahashi, Y., Kishi, H., Taguchi, Y., Takashima, S., Tanaka, K., Muraguchi, A., & Mori, H. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1834 · Cited by 26
Farias‐Moeller, R., Carpenter, J. L., Dean, N., & Wells, E. M. (2015) · Neurocritical Care · doi:10.1007/s12028-015-0124-y · Cited by 26
Transient anti-NMDAR encephalitis in a newborn infant due to transplacental transmission
Hilderink, M., Titulaer, M. J., Schreurs, M. W. J., Keizer, K., & Bunt, J. E. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000126 · Cited by 26
Hinkle, C. D., Porter, J. N., Waldron, E. J., Klein, H., Tranel, D., & Heffelfinger, A. K. (2016) · The Clinical Neuropsychologist · doi:10.1080/13854046.2016.1191676 · Cited by 27
Teratoma-associated anti-NMDAR encephalitis
Liang, Z., Yang, S., Sun, X., Li, B., Li, W., Liu, Z., & Yu, G. (2017) · Medicine · doi:10.1097/md.0000000000009177 · Cited by 26
Liu, B., Xie, Z., Liu, G., Gu, Y., Pan, S., & Wang, H. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.016 · Cited by 26
Paraneoplastic movement disorders
Popławska-Domaszewicz, K., Florczak‐Wyspianska, J., Kozubski, W. P., & Michalak, S. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0081 · Cited by 25
FDG-PET in Autoimmune Encephalitis
Jha, S., Nagaraj, C., Mundlamuri, R. C., Alladi, S., Nashi, S., Kenchaiah, R., Mahadevan, A., Bhat, M. D., Saini, J. S., & Netravathi, M. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_645_22 · Cited by 26
Lenoir, X. F., Sindic, C., Pesch, V. V., Sankari, S. E., de Tourtchaninoff, M., Denays, R., & Hantson, P. E. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9788-8 · Cited by 25
Irani, S. R., & Vincent, A. C. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000400015 · Cited by 26
Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
Hackert, J. K., Müller, L., Rohde, M., Bien, C. G., Köhling, R., & Kirschstein, T. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00130 · Cited by 25
Agitation Management in Pediatric Males with Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Schumacher, L. T., Mann, A. P., & MacKenzie, J. G. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0102 · Cited by 25
Lazzarin, S. M., Vabanesi, M., Cecchetti, G., Fazio, R., Fanelli, G. F., Volonté, M. A., Genchi, A., Giordano, A., Martinelli, V., Colombo, S., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09988-w · Cited by 25
Autoimmunity and NMDA receptor in brain disorders: Where do we stand?
Hunter, D., Jamet, Z., & Groc, L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105161 · Cited by 28
Wang, T., Wang, B., Zeng, Z., Li, H., Zhang, F., Ruan, X., Wang, C., & Guo, S. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577527 · Cited by 25
Autoimmune Encephalitis and Autism Spectrum Disorder
Whiteley, P., Marlow, B. P., Kapoor, R. R., Blagojevic-Stokic, N., & Sala, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.775017 · Cited by 29
Arinrad, S., Wilke, J. B. H., Seelbach, A., Doeren, J., Hindermann, M., Butt, U. J., Steixner-Kumar, A. A., Spieth, L., Ronnenberg, A., Pan, H., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01392-8 · Cited by 23
Liu, X., Fan, K., Lin, Q., Tang, M., Wang, Q., Huang, E., Zhang, W., Chen, T., & Ou, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840003 · Cited by 25
Liu, Y., Tian, Y., Guo, R., Xu, X. P., Zhang, M., Li, Z., Xiao, Y., Cao, W., Gao, H., Kong, D., et al. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/4299791 · Cited by 28
Psychiatric manifestations of autoimmune encephalitis
Ford, H. J., Griffith, S. P., Warren, N., Swayne, A., Blum, S., Butzkueven, H., O'Brien, T. J., Velakoulis, D., Kulkarni, J., & Monif, M. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103145 · Cited by 27
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
Vogrig, A., Gigli, G. L., Nilo, A., Pauletto, G., & Valente, M. (2022) · Biomedicines · doi:10.3390/biomedicines11010044 · Cited by 25
Guo, K., Liu, X., Gong, X., Li, A., Liu, Y., Li, X., Zhou, D., & Hong, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146536 · Cited by 25
NMDARs activation regulates endothelial ferroptosis via the PP2A-AMPK-HMGB1 axis
Han, W.-M., Hong, Y., Xiao, G.-S., Wang, R., & Li, G. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01794-3 · Cited by 26
Kawano, H., Hamaguchi, E., Kawahito, S., Tsutsumi, Y. M., Tanaka, K., Kitahata, H., & Oshita, S. (2011) · Anaesthesia · doi:10.1111/j.1365-2044.2011.06707.x · Cited by 25
Extreme delta brush in a patient with anti‐NMDAR encephalitis
Capua, D. D., Ptacek, S. G., García‐García, M. E., Abarrategui, B., Porta-Etessam, J., & García‐Morales, I. (2013) · Epileptic Disorders · doi:10.1684/epd.2013.0622 · Cited by 25
A case of NMDAR encephalitis misdiagnosed as postpartum psychosis and neuroleptic malignant syndrome
Köksal, A., Baybaş, S., Mutluay, B., Altunkaynak, Y., & Keşkek, A. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1966-3 · Cited by 25
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
Hung, T., Foo, N.-H., & Lai, M. (2011) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2011.08.012 · Cited by 24
Foam sclerotherapy: a possible cause of ischaemic stroke?
Picard, C., Deltombe, B., Duru, C., Godefroy, O., & Bugnicourt, J. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.179952 · Cited by 25
Ando, Y., Shimazaki, H., Shiota, K., Tetsuka, S., Nakao, K., Shimada, T., Kurata, K., Kuroda, J., Yamashita, A., Sato, H., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0948-9 · Cited by 25
Fukushima, N., SUZUKI, M. T., Ogawa, R., Hayashi, K., Takanashi, J., & Ohashi, T. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001078 · Cited by 25
Paraneoplastic Diseases of the Central Nervous System
Galli, J. R., & Greenlee, J. (2020) · F1000Research · doi:10.12688/f1000research.21309.1 · Cited by 25
Causes of CNS Inflammation and Potential Targets for Anticonvulsants
Falip, M., Salas‐Puig, X., & Cara, C. (2013) · CNS Drugs · doi:10.1007/s40263-013-0078-6 · Cited by 26
Complications des tumeurs ovariennes présumées bénignes
Deffieux, X., Thubert, T., Huchon, C., Demoulin, G., Rivain, A.-L., Faivre, E., & Trichot, C. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.09.036 · Cited by 24
Ictal Asystole and Anti–N-Methyl- d -aspartate Receptor Antibody Encephalitis
Millichap, J. G., Goldstein, J. L., Laux, L. C., Nordli, D. R., Stack, C. V., & Wainwright, M. S. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2080 · Cited by 24
Prodromal headache in anti‐ NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
Tominaga, N., Kanazawa, N., Kaneko, A., Kaneko, J., Kitamura, E., Nakagawa, H., Nishiyama, K., & Iizuka, T. (2018) · Brain and Behavior · doi:10.1002/brb3.1012 · Cited by 24
Teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis
Yan, B., Wang, Y., Zhang, Y., & Lou, W. (2019) · Medicine · doi:10.1097/md.0000000000015765 · Cited by 24
Anti-NMDAR encephalitis with ovarian teratomas: Review of the literature and two case reports
Chiu, H.-C., Su, Y.-C., Huang, S., Chiang, H., & Huang, P.-S. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.03.004 · Cited by 25
Liang, Y., Cai, L., Zhou, X., Huang, H., & Zheng, J. (2019) · Neuroradiology · doi:10.1007/s00234-019-02321-x · Cited by 24
IRAK4 Deficiency Presenting with Anti-NMDAR Encephalitis and HHV6 Reactivation
Nishimura, S., Kobayashi, Y., Ohnishi, H., Moriya, K., Tsumura, M., Sakata, S., Mizoguchi, Y., Takada, H., Kato, Z., Sancho‐Shimizu, V., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00885-5 · Cited by 24
Metadata
- Authors
- Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., & Lynch, D. R.
- Affiliations
- University of Pennsylvania (US)
- Augusta University (US)
- Yale University (US)
- Jichi Medical University (JP)
- Tokyo Metropolitan Neurological Hospital (JP)
- Children's Hospital of Pittsburgh (US)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Dalmau, Josep
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 61
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2430743
- OpenAlex
- W2114398221
- Cited by
- 2,492
- References
- 37
- Citations by year
- 2026: 105 · 2025: 122 · 2024: 142 · 2023: 135 · 2022: 168 · 2021: 190 · 2020: 158 · 2019: 179 · 2018: 128 · 2017: 152 · 2016: 158 · 2015: 145 · 2014: 129 · 2013: 143 · 2012: 113
- FWCI
- 47.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA089054, R01CA107192)
- National Institute of Neurological Disorders and Stroke (R01NS045986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- paraneoplastic encephalitis, anti-NMDA receptor encephalitis, ovarian teratoma, NMDA receptor subunits, NR2B, NR2A, autoantibodies, hippocampal neurons, autoimmune encephalitis, tumor resection, immunotherapy, microglial activation, neurodegeneration, psychiatric symptoms, amnesia, seizures
- MeSH terms
- Adolescent, Adult, Animals, Antibodies, Dissection, Encephalitis, Female, Humans, Immunohistochemistry, Immunosuppressive Agents, Magnetic Resonance Imaging, Male, Neurons, Ovarian Neoplasms, Teratoma, Transfection, Gene Expression Regulation, Neoplastic, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Rats, Wistar, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
